Regulation of Osteoblast Migration Involving Receptor Activator of Nuclear Factor-kappa B (RANK) Signaling
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Regulation of Osteoblast Migration Involving Receptor Activator of Nuclear Factor-kappa B (RANK) Signaling
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR PHYSIOLOGY
Volume 230, Issue 12, Pages 2951-2960
Publisher
Wiley
Online
2015-04-20
DOI
10.1002/jcp.25024
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Off-Target Effects of MEK Inhibitors
- (2013) Eric M. Wauson et al. BIOCHEMISTRY
- Acute Mitochondrial Inhibition by Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase Kinase (MEK) 1/2 Inhibitors Regulates Proliferation
- (2012) Maureen O. Ripple et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Reciprocal osteoblastic and osteoclastic modulation in co-cultured MG63 osteosarcoma cells and human osteoclast precursors
- (2011) João Costa-Rodrigues et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- RANK-Fc inhibits malignancy via inhibiting ERK activation and evoking caspase-3-mediated anoikis in human osteosarcoma cells
- (2010) Toru Akiyama et al. CLINICAL & EXPERIMENTAL METASTASIS
- Emerging MEK inhibitors
- (2010) James A McCubrey et al. EXPERT OPINION ON EMERGING DRUGS
- Development and characterization of a conditionally immortalized human fetal osteoblastic cell line
- (2010) Steven A. Harris et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Involvement of integrin up-regulation in RANKL/RANK pathway of chondrosarcomas migration
- (2010) Chin-Jung Hsu et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- RDEA119/BAY 869766: A Potent, Selective, Allosteric Inhibitor of MEK1/2 for the Treatment of Cancer
- (2009) C. Iverson et al. CANCER RESEARCH
- In vivo Antitumor Activity of MEK and Phosphatidylinositol 3-Kinase Inhibitors in Basal-Like Breast Cancer Models
- (2009) K. P. Hoeflich et al. CLINICAL CANCER RESEARCH
- Lysophosphatidic acid-induced ERK activation and chemotaxis in MC3T3-E1 preosteoblasts are independent of EGF receptor transactivation
- (2009) Sue A. Karagiosis et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Increased RANKL expression is related to tumour migration and metastasis of renal cell carcinomas
- (2009) Shuji Mikami et al. JOURNAL OF PATHOLOGY
- Extracellular Signal-Regulated Kinase 1 (ERK1) and ERK2 Play Essential Roles in Osteoblast Differentiation and in Supporting Osteoclastogenesis
- (2009) T. Matsushita et al. MOLECULAR AND CELLULAR BIOLOGY
- The EGFR network in bone biology and pathology
- (2009) Marlon R. Schneider et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- IGF-I secreted by osteoblasts acts as a potent chemotactic factor for osteoblasts
- (2008) Manando Nakasaki et al. BONE
- Down-regulation of the PI3-kinase/Akt pathway by ERK MAP kinase in growth factor signaling
- (2008) Hideko Hayashi et al. GENES TO CELLS
- Chemotaxis of human articular chondrocytes and mesenchymal stem cells
- (2008) Yasunori Mishima et al. JOURNAL OF ORTHOPAEDIC RESEARCH
- Osteoblast proliferation or differentiation is regulated by relative strengths of opposing signaling pathways
- (2007) Angela Raucci et al. JOURNAL OF CELLULAR PHYSIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started